Amgen's $936 Million Trading Day Ranks 68th Amid CIBC's Bullish Bet and Dividend Boost

On April 1, 2025, Amgen's trading volume reached $936 million, ranking 68th in the day's stock market activity. The company's stock price decreased by 1.49%.

CIBC has increased its position in Amgen Inc. (NASDAQ:AMGN), indicating a bullish outlook on the company's future prospects. This move suggests confidence in Amgen's strategic direction and financial performance.

Amgen recently declared a quarterly dividend of $2.38 per share, payable on June 6, 2025. This dividend is for stockholders of record as of May 16, 2025, highlighting the company's commitment to returning value to its shareholders.

Amgen has demonstrated strong dividend growth, increasing its payouts by 201% over the past decade. With a forward yield of around 3.7%, Amgen is positioned as an attractive dividend growth stock for long-term investors.